Ignite Creation Date:
2024-05-06 @ 12:13 PM
Last Modification Date:
2024-10-26 @ 12:55 PM
Study NCT ID:
NCT03703050
Status:
RECRUITING
Last Update Posted:
2024-06-11
First Post:
2018-10-09
Brief Title:
Nivolumab for Pediatric and Adult RelapsingRefractory ALK for Evaluation of Response in Patients With Progressive Disease Cohort 1 or as Consolidative Immunotherapy in Patients in Complete Remission After Relapse Cohort 2
Sponsor:
Gustave Roussy Cancer Campus Grand Paris
Organization:
Gustave Roussy Cancer Campus Grand Paris
Organization Data
Organization:
Gustave Roussy Cancer Campus Grand Paris
Class:
OTHER
Study ID:
2018-001447-31
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Gustave Roussy Cancer Campus Grand Paris
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None